Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 992

1.

A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral.

Patel MX, de Zoysa N, Bernadt M, David AS.

J Clin Psychiatry. 2008 Oct;69(10):1548-56. Epub 2008 Sep 23.

PMID:
19192437
2.

Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.

Patel MX, De Zoysa N, Bernadt M, David A.

J Psychopharmacol. 2009 Sep;23(7):789-96. doi: 10.1177/0269881108092124. Epub 2008 Jun 26.

PMID:
18583438
3.

Are depot antipsychotics more coercive than tablets? The patient's perspective.

Patel MX, de Zoysa N, Bernadt M, Bindman J, David AS.

J Psychopharmacol. 2010 Oct;24(10):1483-9. doi: 10.1177/0269881109103133. Epub 2009 Mar 20.

PMID:
19304865
4.

Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.

Valenstein M, Copeland LA, Owen R, Blow FC, Visnic S.

J Clin Psychiatry. 2001 Jul;62(7):545-51.

PMID:
11488366
5.

Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C.

Arch Gen Psychiatry. 2005 Jul;62(7):717-24.

PMID:
15997012
6.

Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.

Patel MX, Nikolaou V, David AS.

Psychol Med. 2003 Jan;33(1):83-9.

PMID:
12537039
7.

A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.

Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM.

J Clin Psychiatry. 2009 Oct;70(10):1397-406. doi: 10.4088/JCP.09m05284yel.

PMID:
19906343
8.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
9.

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.

Ascher-Svanum H, Peng X, Faries D, Montgomery W, Haddad PM.

BMC Psychiatry. 2009 Jul 29;9:46. doi: 10.1186/1471-244X-9-46.

10.

Injections of depot antipsychotic medications in patients suffering from schizophrenia: do they hurt?

Bloch Y, Mendlovic S, Strupinsky S, Altshuler A, Fennig S, Ratzoni G.

J Clin Psychiatry. 2001 Nov;62(11):855-9.

PMID:
11775044
11.

Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.

Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman J, Schene A, Nosè M, Helm H, Thornicroft G, Tansella M.

Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973. Epub 2009 Aug 11.

PMID:
19672133
12.

A pilot study of barriers to medication adherence in schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G.

J Clin Psychiatry. 2004 Feb;65(2):211-6.

PMID:
15003075
13.

Treatment adherence in schizophrenia and schizoaffective disorder.

Goff DC, Hill M, Freudenreich O.

J Clin Psychiatry. 2011 Apr;72(4):e13. doi: 10.4088/JCP.9096tx6cc.

14.

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.

Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC.

J Clin Psychiatry. 2004 Oct;65(10):1372-6.

PMID:
15491241
15.

How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.

Beck EM, Cavelti M, Wirtz M, Kossowsky J, Vauth R.

Psychiatry Res. 2011 May 15;187(1-2):55-61. doi: 10.1016/j.psychres.2010.10.012. Epub 2010 Nov 12.

PMID:
21074860
16.

[Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].

Misdrahi D, Llorca PM, Lançon C, Bayle FJ.

Encephale. 2002 May-Jun;28(3 Pt 1):266-72. French.

PMID:
12091789
17.

Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.

Fujikawa M, Togo T, Yoshimi A, Fujita J, Nomoto M, Kamijo A, Amagai T, Uchikado H, Katsuse O, Hosojima H, Sakura Y, Furusho R, Suda A, Yamaguchi T, Hori T, Kamada A, Kondo T, Ito M, Odawara T, Hirayasu Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):755-60. doi: 10.1016/j.pnpbp.2007.12.002. Epub 2007 Dec 14.

PMID:
18226436
18.

Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.

Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM, Fleischhacker WW.

J Clin Psychiatry. 2004 Sep;65(9):1211-8.

PMID:
15367047
19.

Predictors for starting depot administration of risperidone in chronic users of antipsychotics.

Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H.

J Clin Psychopharmacol. 2008 Dec;28(6):625-30. doi: 10.1097/JCP.0b013e31818a6d10.

PMID:
19011430
20.

Factors associated with medication adherence in African American and white patients with bipolar disorder.

Fleck DE, Keck PE Jr, Corey KB, Strakowski SM.

J Clin Psychiatry. 2005 May;66(5):646-52.

PMID:
15889954

Supplemental Content

Support Center